Andrea LC Reid

Andrea L.C. Reid counsels established and start-up clients in all sectors of the biotech and pharmaceutical industries on developing intellectual property issues, policies, patent portfolio management and filing strategies at all phases of the business cycle. Ms. Reid’s ability to develop IP strategies for start-up clients has resulted in more than US$3.7 billion in acquisition and investor/partner funding. With nearly 30 years of experience working in the pharmaceutical industry, she has extensive experience in all areas of drug discovery through drug development. She draws on this experience when prosecuting patent applications and preparing patentability, validity and infringement opinions involving active pharmaceutical ingredients, manufacturing syntheses and formulations. She regularly represents clients on specialty issues relating to organic chemistry, small molecule pharmaceuticals and polymorph intellectual property.

Sought for her unique breadth of knowledge, Ms. Reid advises patent litigators on technical scientific concepts in complex pharmaceutical patent maters. Additionally, she represents clients in intellectual property due diligence issues and assesses matters connected to in-license and acquisition opportunities.

Ms. Reid is listed among the Top 250 Women in IP by Managing Intellectual Property Magazine and has been recognized by the Managing Intellectual Property Magazine as an IP Star. She is routinely named a Massachusetts Super Lawyers Rising Star and was also named a World’s Leading Patent Practitioner by IAM Patent 1000 who referred to her as a “consummate strategist” for her ability to “draw on a quarter century’s worth of experience in pharmaceuticals [when providing] sage guidance across the patent lifecycle.”

Prior to joining Dechert, Ms. Reid served as an intellectual property partner at a Boston based law firm. Her previous experience also includes working as a patent agent at a global biotechnology company where she prepared and prosecuted small molecule patent applications for the Protein Kinase gene family and bacterial Gyrase programs. Ms. Reid also worked as a chemist for 14 years in which time she completed several natural product syntheses, worked as both a medicinal and process chemist, was an inventor on 14 United States Patents and co-author of numerous scientific publications.

Good to know

Job Types Partner
Areas of Practice 1) Intellectual Property, 2) Intellectual Property Litigation, 3) Patent Litigation, 4) Patent Counseling and Prosecution, 5) Health and 6) Life Sciences
Law School Suffolk University Law School (J.D.,2006)
Education University of Massachusetts Lowell (M.S.,1997);Boston University (B.A., Chemistry, 1987)
Bar Member / Association Massachusetts State Bar Association
Most recent firm Dechert LLP
LinkedIn Profile https://www.linkedin.com/in/andrea-l-c-reid-a969414
Relevant Jobs
Associate Attorney - Defense Litigation Experience
USA-TX-Dallas

Galloway's Dallas office is seeking an Associate Attorneys with 1 - 2 years of experience to handle civil defense litigation in a variety of practice areas. Qualified candidates will be self-starter...

Apply now

Litigation Employment Attorney (Remote) in Burbank, CA.
USA-CA-Burbank

     We are a small and highly respected Burbank based REMOTE employment litigation defense firm. We represent public entities and public agencies in civil lawsuits.  We are seeking an experienced...

Apply now

+ View more jobs
Barbara A. Fitzgerald
Barbara A. Fitzgerald

Ms. Fitzgerald represents employers in a wide range of industries, including the entertainment, financial services, hospitality, manufacturing, retail, and transportation industries.

Barbara J. Shander
Barbara J. Shander

Ms. Shander advises public and private company clients as well as private equity funds, with an emphasis on mergers and acquisitions, dispositions, and financing transactions.

Barton W S Bassett
Barton W S Bassett

Barton W.S. Bassett is the leader of Morgan Lewis's Tax Practice. Mr. Bassett's practice focuses on international tax planning for both the outbound operations of U.S. multinationals and the inbound operations of foreign multinationals.